1,910 search results for “cancer progression” in the Public website
-
New professor wants to improve care for sarcoma patients
Doctors should work with patients with bone and soft-tissue tumours to find the best personal treatment strategy says Prof. Michiel den de Sande. He has developed an app that helps choose the right treatment. Van de Sande was appointed Professor of Orthopaedics with a particular focus on paediatric…
-
Why Leiden University?
We are committed to provide you with meaningful, rigorous and quality graduate experiences in a personalized environment with a cutting edge research infrastructure and internationally renowned supervisors.
-
4 Year Trajectory Plan
Most employed and contract PhD candidates at the Faculty of Humanities follow a 4-year PhD track.
-
Dynamic testing and excellence
Unfolding potential
- Facilities
-
NL-BioImaging AM
NL-BioImaging AM is a distributed research infrastructure aimed at promoting progress in the most cutting edge microscopy technologies and providing open access to these technologies to a broad community of academic and industrial users. All Netherlands bio(medical) microscopy centers participate.
-
PhD Meetings & Portfolio
You will be advised by a PhD Advisory Committee (PAC) that is appointed especially for you. Typically the members of the PAC are: the LACDR Scientific Director, your promotor(s), if applicable, your co-promotor(s) and an external advisor.
-
Scientists find strong evidence that wasting syndrome is the same for all organisms
An interdisciplinary team of Leiden researchers has discovered that wasting syndrome, a severe byproduct of tuberculosis, is the same for all humans and animals studied. The discovery offers new opportunities to investigate the still insufficiently understood condition. The scientists also developed…
-
Refining individualized treatment in older patients with breast cancer
PhD defence
-
Next generation sequencing of ovarian metastases of colorectal cancer
PhD defence
-
Learning from best performers in colorectal cancer surgery
PhD defence
-
Molecular Biomarkers and Treatment Strategies in Resectable Pancreatic Cancer
PhD defence
-
Improving Diagnostic, Prognostic and Predictive Biomarkers in Colorectal Cancer
PhD defence
-
Mechanisms underlying success and failure of cancer immunotherapy
PhD defence
-
Functional characterization of BRCA2 variants to improve cancer risk assessment
PhD defence
-
Interplay between cancer and thrombosis; identification of key factors
PhD defence
-
Quality assurance in breast cancer care and breast implant surgery
PhD defence
-
Coagulopathy and blood abnormalities in cancer and inflammation
PhD defence
-
Ductal carcinoma in situ of the breast: cancer precursor or not?
PhD defence
-
Exploring Grainyhead-like 2 target genes in breast cancer
PhD defence
-
Immune cell complexity in the tumor microenvironment of breast cancer
PhD defence
-
Multiparametric MRI for focal dose escalation in prostate cancer radiotherapy
PhD defence
-
Glycoproteomics-based signatures of cancer cell lines
PhD defence
-
Unraveling mucin type o-glycosylation signatures of colorectal cancer
PhD defence
-
Novel treatment for advanced thyroid cancer and elucidation of biomarkers
PhD defence
-
Diagnostic and Intraoperative Targeted Molecular Imaging for Pancreatic Cancer
PhD defence
-
Quality assurance in the surgical treatment of gastric cancer
PhD defence
-
Tamoxifen pharmacogenetics and pharmacokinetics in early-breast cancer
PhD defence
-
Risk Quantification and Modification in Older Patients with Colorectal Cancer
PhD defence
-
In vivo mechanisms of antibody-based cancer immunotherapy
PhD defence
-
Combinatorial prospects of nanoparticle mediated immunotherapy of cancer
PhD defence
-
Towards a tailored therapeutic approach for vulvar cancer patients
PhD defence
-
Cancer and sexual health: the continuum of care
PhD defence
-
Discovery of genetic defects in unexplained colorectal cancer syndromes
PhD defence
-
Reducing uncertainties in image-guided radiotherapy of rectal cancer
PhD defence
-
Tailoring the tools to study prostate cancer metastasis
PhD defence
-
Picturing Student Progress: Teachers' Comprehension of Curriculum- based Measurement Progress Graphs
PhD defence
-
Uncovering vulnerabilities in triple-negative breast cancer
PhD defence
-
Precision modeling of breast cancer in the CRISPR era
PhD defence
-
Targeted Therapy for Triple-Negative Breast Cancer
PhD defence
-
A comprehensive approach for quality assurance of breast cancer care
PhD defence
-
Hanging in there: Exploring the heritability of breast cancer survival
PhD defence
-
The tumor-stroma ratio in epithelial cancer types
PhD defence
-
Discovery of BUB1 kinase inhibitors for the treatment of cancer
PhD defence
-
Cancer Chess: Molecular Insights into PARP Inhibitor Resistance
PhD defence
-
PI3K signaling and adherens junctions in invasive lobular breast cancer
PhD defence
- ELS Lab Meeting – Work in Progress Session
-
Medicine/Leiden University Medical Center
We are very happy to welcome you to spend a semester or year studying or doing an internship with us at the Leiden University Medical Center. Here you will find information on your course timetables and registration.
-
Discovery of Reversible Monoacylglycerol Lipase Inhibitors
Monoacylglycerol lipase (MAGL) is the principal enzyme responsible for hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-AG). MAGL inhibition provides several potential therapeutic opportunities, including anti-nociceptive, anti-inflammatory and anti-cancer activity.
-
Single cell technologies for mechanobiology and mechanopharmacology
Mechanobiology is a major area in biology, however, mechanics is currently a missing element in drug development pipelines. This has led to a high cost for the society. Mechanotoxicity of drugs often appears as a long-term side effect of drugs, and has led to removal of drugs from the market. Furthermore,…